| Barklie Waters Zimmerman, MD | |
|
7811 Forest Avenue, Suite 300, Richmond, VA 23229-4920 | |
| (804) 968-4435 | |
| (804) 968-4463 |
| Full Name | Barklie Waters Zimmerman |
|---|---|
| Gender | Male |
| Speciality | Surgery - Vascular Surgery |
| Location | 7811 Forest Avenue, Richmond, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770531618 | NPI | - | NPPES |
| 007364644 | Medicaid | VA | |
| VAA104105 | Other | VA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 0101039362 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barklie Waters Zimmerman, MD 7611 Forest Ave, Suite 300, Richmond, VA 23229-4946 Ph: (804) 968-4435 | Barklie Waters Zimmerman, MD 7811 Forest Avenue, Suite 300, Richmond, VA 23229-4920 Ph: (804) 968-4435 |
News Archive
Mate guarding is classified as excessive or unwarranted jealous or protective behavior towards a spouse or mate. This is common among many different species and can be useful to defend territory, guarantee paternity, or prevent disease. The authors of a new study published in Personal Relationships have discovered that this behavior is more common in societies which practice arranged marriages or in cultures that place a high value on parental influence in the choice of mate for their children.
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids. The results were reported by U.S. Military HIV Research Program (MHRP) researchers on Aug. 25 in the online version of AIDS, the official journal of the International AIDS Society.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.
› Verified 1 days ago
Dr. Jeannie Rivers, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: Box 112 Surgical Service/mcguire Vamc, 1201 Broad Rock Blvd, Richmond, VA 23249 Phone: 804-675-5112 | |
Amit Sharma, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 E Marshall St, Richmond, VA 23298 Phone: 804-828-4104 Fax: 804-828-0854 | |
Jessica Anne Frankenhoff, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall St, Orthopaedic Surgery, Richmond, VA 23298 Phone: 804-828-7051 Fax: 804-828-7199 | |
Diane Renee Cox, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1051 Johnston Willis Dr, St 200, Richmond, VA 23235 Phone: 804-320-2705 Fax: 804-330-2433 | |
Matthew Macey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9101 Stony Point Dr, Richmond, VA 23235 Phone: 804-330-9105 Fax: 804-287-6119 | |
Francisco Cabral Albuquerque Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall St, Surgery, Richmond, VA 23298 Phone: 804-828-3211 Fax: 804-827-2744 | |
Dr. Emily Burke Rivet, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall St, Dept. Of Surgery/bariatric & Gastrointestinal, Richmond, VA 23298 Phone: 804-327-8001 Fax: 804-327-8002 |